Advice
In the absence of a submission from the holder of the marketing authorisation:
tapentadol film-coated tablets (Palexia®) is not recommended for use within NHS Scotland.
Indication under review: relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice38KB (PDF)
Medicine details
- Medicine name:
- tapentadol film-coated tablets (Palexia)
- SMC ID:
- 773/12
- Indication:
- Moderate to severe acute pain in adults
- Pharmaceutical company
- Grünenthal Ltd
- BNF chapter
- Central nervous system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 February 2012